The oxytocin receptor
Hans H Zingg1, Stephane A Laporte
1Laboratory of Molecular Endocrinology, McGill University Health Centre, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada. hans.zingg@mcgill.ca
Abstract:
Novel sites of oxytocin receptor expression have recently been detected, including breast cancer cells, bone cells, myoblasts, cardiomyocytes and endothelial cells. These discoveries have greatly expanded the possible spectrum of oxytocin action beyond its classic role as an inducer of uterine contractions and milk ejection. Additional advances in the understanding of oxytocin receptor structure-function relationships, receptor trafficking and novel receptor-linked signaling cascades have made this receptor an attractive model for the study of G-protein-linked receptor function. Finally, the tocolytic efficiency of the oxytocin receptor antagonist atosiban, recently approved for clinical use in Europe, has opened new avenues for the prevention and treatment of preterm labor.
Insights
Oxytocin receptors are now found in various cells beyond the uterus, expanding their known functions. Research into these receptors offers new therapeutic targets for conditions like preterm labor.
Area of Science:
- Endocrinology
- Molecular Biology
- Pharmacology
Background:
- Oxytocin's traditional roles in uterine contractions and milk ejection are well-established.
- Recent findings reveal oxytocin receptor expression in diverse cell types, including cancer cells, bone cells, and cardiovascular cells.
- Advances in understanding receptor structure, trafficking, and signaling pathways are ongoing.
Purpose of the Study:
- To explore the expanded roles and implications of novel oxytocin receptor expression sites.
- To highlight the significance of oxytocin receptor research in G-protein-linked receptor studies.
- To discuss the therapeutic potential of oxytocin receptor antagonists in managing preterm labor.
Main Methods:
- Literature review of recent discoveries in oxytocin receptor expression.
- Analysis of structure-function relationships and signaling cascades.
- Examination of clinical data regarding oxytocin receptor antagonist efficacy.
Main Results:
- Oxytocin receptors are expressed in breast cancer cells, bone cells, myoblasts, cardiomyocytes, and endothelial cells.
- This broad expression pattern suggests novel functions for oxytocin.
- The oxytocin receptor antagonist atosiban demonstrates efficacy in preventing preterm labor.
Conclusions:
- The discovery of novel oxytocin receptor sites significantly broadens the understanding of oxytocin's physiological and pathological roles.
- The oxytocin receptor serves as a valuable model for studying G-protein-linked receptor mechanisms.
- Atosiban's clinical approval offers new therapeutic strategies for preterm labor management.
Related Concept Videos
Neurotransmitters
Opioid Receptors: Overview
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor-mediated Endocytosis
Receptor-Mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Intracellular Hormone Receptors

